Essential Medicines List for Palliative Care - PowerPoint PPT Presentation

1 / 20
About This Presentation
Title:

Essential Medicines List for Palliative Care

Description:

... palliative care services keep ' re-inventing the wheel' making the same ... attention of all students of medicine and nursing, and especially all intending ... – PowerPoint PPT presentation

Number of Views:29
Avg rating:3.0/5.0
Slides: 21
Provided by: off6123
Category:

less

Transcript and Presenter's Notes

Title: Essential Medicines List for Palliative Care


1
Essential Medicines List for Palliative Care
  • Salzburg 2006

2
We are here today because....
  • We are committed to providing, and encouraging
    others to provide, the highest standards of
    palliative care world-wide.
  • We bring to this meeting vast experience in
    palliative care in countries very different from
    each other but all with thousands of people
    needing palliative care.

3
We are here because
  • There are now gt 8,200 palliative care services
    world-wide
  • Increasingly such services are Hospital
    Palliative Care Teams in secondary and tertiary
    referral hospitals
  • Palliative care training of doctors and nurses in
    many developing countries is still minimal. They
    are eager to learn.
  • All, whether in a developed or a developing
    country, need as much help as we can give them

4
We are here because, hopefully, we would all
agree that
5
Every person with a life-threatening illness has
the right to receive appropriate palliative care
  • Irrespective of their colour, class, creed, or
    financial means

6
It is the responsibility of every clinician to
provide appropriate palliative care to those who
need it
  • ( Such care might not always be given by a
    primary care doctor but might mean the patient
    being referred to a palliative care service or
    advice sought from one )

7
Patients receiving palliative care should be
enabled to receive it in the place of their
choice - home, hospital, hospice, nursing or
care home.
  • The options vary from country to country as do
    the chances of patients achieving their wishes

8
Many of us know from experience..,,
  • That people or groups starting palliative care
    services keep re-inventing the wheel making
    the same mistakes we have all made, trying out
    therapeutic regimens we have already found
    ineffective or too costly.
  • Many of our textbooks are too expensive for those
    in developing countries
  • These are some of the reasons why the WHO
    Analgesic Ladder was needed and why we are here
    to produce an Essential Medicines List

9
Like the WHO ladder the Essential Medicines
List...
  • Will not be prescriptive or legally-binding
  • Will not suggest therapeutic regimens
  • Will not deal with financial costs (though they
    will be well known to most of us)
  • Will represent the distillation of our clinical
    experience with 100,000s of patients
  • Will, hopefully, be easy to explain,
    substantiate, disseminate and update.

10
The Essential Medicines List
  • The question of cost and value for money will
    be addressed by those who follow me.
  • The question of robust evidence on efficacy of
    medicines in the list will be addressed by others
    who follow me
  • Here we address the need for a list and the
    principles associated with its use and
    dissemination world-wide.

11
The Essential Medicines List
  • Will not contain proprietary preparations
  • or deliberately encourage their use
  • Will predictably contain some medicines not
    available in countries we represent
  • Will be reviewed and updated on a regular basis
  • Will carry the authority of the WHO
  • Question Are we agreed on that ?

12
The Essential Medicines List will be of little
use unless
  • Governments legislate for availability and
    accessibility of the listed medicines for
    patients wherever they are being cared for.
  • This applies to all on the list and not only
    opioids.
  • Question How do we influence governments
  • and make this happen ?

13
It will be useless unless.
  • It is brought to the attention of, and explained
    to, all bodies briefing and trying to influence
    members of parliament and departments of health.
  • Such bodies now function in many countries
    explaining palliative care and encouraging
    government support and appropriate legislation
  • Question How do we establish such lobbying
    groups and keep them informed ?

14
It will be of little use unless..
  • It is brought to the attention of all physicians
    and nurses working in generalist and specialist
    palliative care services
  • Question How do we achieve this ?
  • It is brought to the attention of all doctors and
    nurses providing palliative care, whatever their
    specialty.
  • Question How do we achieve this ?

15
It will be useless unless ..
  • It is brought to the attention of all
    pharmacists, wherever they work
  • Question How do we achieve this ?
  • It is brought to the attention of all students of
    medicine and nursing, and especially all
    intending to practise palliative care.
  • Question How do we achieve this ?

16
It will be useless unless.
  • It is brought to the attention of all charities
    involved in supporting / funding/ enabling
    Palliative Care worldwide.
  • Question How do we achieve this ?
  • It is brought to the attention of all national
    and international professional associations /
    societies of those working in palliative care
  • Question How do we achieve this ?

17
It will be of little use unless.
  • It is brought to the attention of editors of
    medical, nursing and pharmaceutical journals and
    given good coverage by them
  • (This is particularly important for all
    journals dedicated to palliative medicine and
    palliative care issues)
  • Question How do we achieve this ?

18
What are your brief comments on..
  • The need for a WHO Essential Medicines List
  • Lobbying for availability and accessibility
  • Making it known to all doctors and nurses
  • Making it known to all students and pharmacists
  • Making it known to professional associations
  • Making it known to editors of professional
    journals
  • Making it known to palliative care charities
  • Have I missed out anything vitally important
    ?

19
A few final thoughts and questions !
  • How often should the list be reviewed and updated
    ?
  • Should each country adapt the list to take costs
    into account ?
  • Are we prepared for the displeasure and
    criticisms of pharmaceutical companies if they
    see the list as threatening sales ?

20
Thank You
Write a Comment
User Comments (0)
About PowerShow.com